BioSpace News Archive

Perrigo Company plc today announced that it will release its third quarter calendar year 2018 financial results on Thursday, November 8, 2018. The Company will host a conference call beginning at 8:30 a.m. (EST).

Women and minorities encouraged to apply; deadline is Dec. 17, 2018

Pain Relief from CybroCell™ Dermal Fibroblasts Could Eliminate Need for Opioids in Some Patients

Israel-Cannabis has partnered with Polish biologist and entrepreneur, Rafał Ślusarczyk, to form Cannabinit, a new company that utilizes revolutionary technology to produce high quality plant cells in vitro.

First dedicated Philips ultrasound solution for breast assessment, combining advanced imaging, full solution elastography, screening and precision biopsy

Laurent Pharmaceuticals Inc. today announced new financing led by Keiretsu Forum Mid-Atlantic, Anges Quebec and Anges Quebec Capital, with participation from existing investors RSJ Gradus, Aligo Innovation, and Cystic Fibrosis Canada. Members from other Keiretsu Forum chapters also invested, as well as a select group of new and existing private individuals.

Impax Laboratories LLC today announced that in collaboration with the U.S. Food and Drug Administration (FDA), the Company is extending the expiration dates for certain lots of its epinephrine injection, USP auto-injector, 0.15 mg and 0.3 mg, the authorized generic of Adrenaclick®.

Dr. J. Stephen Jones selected to oversee new peer-reviewed journal

Halloween can be a fun and exciting time for children of all ages. To ensure it’s also a safe experience, parents and caregivers are encouraged to follow these important safety tips.

Data Demonstrate Proprietary Digital At-Home Monitoring Technology Increases Patient Adherence to NPWT